Literature DB >> 28484856

[Hereditary gastric and pancreatic cancer].

C Langner1.   

Abstract

Most cases of gastric and pancreatic cancer are sporadic, but familial clustering can be observed in approximately 10% of cases. Hereditary gastric cancer accounts for a very low percentage of cases (1-3%) and two syndromes have been characterized: hereditary diffuse gastric cancer (HDGC) and gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS). Gastric and pancreatic cancer can develop in the setting of other hereditary cancer syndromes, such as hereditary breast and ovarian cancer syndrome (HBOC), Li-Fraumeni syndrome, Lynch syndrome, familial adenomatous polyposis (FAP), or various hamartomatous polyposis syndromes, including juvenile polyposis and Peutz-Jeghers syndrome. Patients with hereditary pancreatitis carry an increased risk of cancer (40-55%).

Entities:  

Keywords:  Familial gastric cancer; Familial pancreatic cancer; Hereditary cancer; Histopathology; Molecular biology

Mesh:

Year:  2017        PMID: 28484856     DOI: 10.1007/s00292-017-0297-6

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  49 in total

1.  Periodic acid-schiff is superior to hematoxylin and eosin for screening prophylactic gastrectomies from CDH1 mutation carriers.

Authors:  Anna F Lee; Henrike Rees; David A Owen; David G Huntsman
Journal:  Am J Surg Pathol       Date:  2010-07       Impact factor: 6.394

2.  Pedigree of a family with hereditary chronic relapsing pancreatitis.

Authors:  M W COMFORT; A G STEINBERG
Journal:  Gastroenterology       Date:  1952-05       Impact factor: 22.682

Review 3.  Familial pancreatic cancer--status quo.

Authors:  Volker Fendrich; Peter Langer; Detlef K Bartsch
Journal:  Int J Colorectal Dis       Date:  2013-08-16       Impact factor: 2.571

4.  Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.

Authors:  Samantha Hansford; Pardeep Kaurah; Hector Li-Chang; Michelle Woo; Janine Senz; Hugo Pinheiro; Kasmintan A Schrader; David F Schaeffer; Karey Shumansky; George Zogopoulos; Teresa Almeida Santos; Isabel Claro; Joana Carvalho; Cydney Nielsen; Sarah Padilla; Amy Lum; Aline Talhouk; Katie Baker-Lange; Sue Richardson; Ivy Lewis; Noralane M Lindor; Erin Pennell; Andree MacMillan; Bridget Fernandez; Gisella Keller; Henry Lynch; Sohrab P Shah; Parry Guilford; Steven Gallinger; Giovanni Corso; Franco Roviello; Carlos Caldas; Carla Oliveira; Paul D P Pharoah; David G Huntsman
Journal:  JAMA Oncol       Date:  2015-04       Impact factor: 31.777

5.  Clinical and pathologic features of familial pancreatic cancer.

Authors:  Jeremy L Humphris; Amber L Johns; Skye H Simpson; Mark J Cowley; Marina Pajic; David K Chang; Adnan M Nagrial; Venessa T Chin; Lorraine A Chantrill; Mark Pinese; R Scott Mead; Anthony J Gill; Jaswinder S Samra; James G Kench; Elizabeth A Musgrove; Katherine M Tucker; Allan D Spigelman; Nic Waddell; Sean M Grimmond; Andrew V Biankin
Journal:  Cancer       Date:  2014-10-14       Impact factor: 6.860

Review 6.  Familial pancreatic cancer.

Authors:  Gloria M Petersen
Journal:  Semin Oncol       Date:  2016-09-22       Impact factor: 4.929

7.  Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients.

Authors:  Chanjuan Shi; Alison P Klein; Michael Goggins; Anirban Maitra; Marcia Canto; Syed Ali; Richard Schulick; Emily Palmisano; Ralph H Hruban
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

Review 8.  Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.

Authors:  Parry Guilford; Bostjan Humar; Vanessa Blair
Journal:  Gastric Cancer       Date:  2010-04-07       Impact factor: 7.370

9.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

Review 10.  Hereditary diffuse gastric cancer: diagnosis and management.

Authors:  Vanessa Blair; Iain Martin; David Shaw; Ingrid Winship; Dale Kerr; Julie Arnold; Pauline Harawira; Maybelle McLeod; Susan Parry; Amanda Charlton; Michael Findlay; Brian Cox; Bostjan Humar; Helen More; Parry Guilford
Journal:  Clin Gastroenterol Hepatol       Date:  2006-03       Impact factor: 11.382

View more
  2 in total

Review 1.  [Early stage pancreatic cancer].

Authors:  C Kahlert; M Distler; D Aust; L Gieldon; J Weitz; T Welsch
Journal:  Chirurg       Date:  2018-04       Impact factor: 0.955

2.  Gankyrin Drives Malignant Transformation of Gastric Cancer and Alleviates Oxidative Stress via mTORC1 Activation.

Authors:  Bo Huang; Weiyang Cai; Qian Wang; Feng Liu; Ming Xu; Yanjie Zhang
Journal:  Oxid Med Cell Longev       Date:  2018-10-21       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.